MYOPACE
LIVE

Serial Number

79235153

Owner

FIAB S.p.A.

Filing Date

Mar 14, 2018

Add to watchlist:

No watchlists yet
View on USPTO

MYOPACE Trademark

Serial Number: 79235153 • Registration: 5742190

MYOPACE is a trademark filed by FIAB S.p.A. on March 14, 2018. The trademark is classified under Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

FIAB S.p.A. (3 trademarks)

Via Paolo Costoli, 4

Entity Type: 09

Trademark Details

Filing Date

March 14, 2018

Registration Date

May 7, 2019

Published for Opposition

February 19, 2019

Cancellation Date

November 21, 2025

Goods & Services

Cardiac electrodes; electrodes for medical use; medical needles for cardiovascular use; needles for surgical use; needles for medical purposes; medical devices for controlling cardiac arrhythmia; pacemaker leads; heart rate monitoring apparatus; medical instruments for cardiac stimulation

Filing History

CANCELLED SECTION 71
Nov 21, 2025 C71T
FINAL DECISION TRANSACTION PROCESSED BY IB
Sep 13, 2019 FINV
FINAL DISPOSITION NOTICE SENT TO IB
Aug 29, 2019 FICS
FINAL DISPOSITION PROCESSED
Aug 29, 2019 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 7, 2019 FICR
REGISTERED-PRINCIPAL REGISTER
May 7, 2019 R.PR
PUBLISHED FOR OPPOSITION
Feb 19, 2019 PUBO
NOTIFICATION PROCESSED BY IB
Feb 16, 2019 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 30, 2019 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 30, 2019 OP2R
NOTICE OF PUBLICATION
Jan 30, 2019 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 7, 2019 CNSA
REFUSAL PROCESSED BY IB
Aug 4, 2018 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 18, 2018 RFCS
REFUSAL PROCESSED BY MPU
Jul 18, 2018 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 7, 2018 RFCR
NON-FINAL ACTION WRITTEN
Jul 6, 2018 CNRT
APPLICATION FILING RECEIPT MAILED
Jul 6, 2018 MAFR
ASSIGNED TO EXAMINER
Jul 2, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 2, 2018 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 28, 2018 REPR